Correlation Between Beam Therapeutics and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both Beam Therapeutics and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Beam Therapeutics and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Beam Therapeutics and Verve Therapeutics, you can compare the effects of market volatilities on Beam Therapeutics and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Beam Therapeutics with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Beam Therapeutics and Verve Therapeutics.
Diversification Opportunities for Beam Therapeutics and Verve Therapeutics
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Beam and Verve is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Beam Therapeutics and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Beam Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Beam Therapeutics are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Beam Therapeutics i.e., Beam Therapeutics and Verve Therapeutics go up and down completely randomly.
Pair Corralation between Beam Therapeutics and Verve Therapeutics
Given the investment horizon of 90 days Beam Therapeutics is expected to under-perform the Verve Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Beam Therapeutics is 1.54 times less risky than Verve Therapeutics. The stock trades about -0.16 of its potential returns per unit of risk. The Verve Therapeutics is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 516.00 in Verve Therapeutics on October 20, 2024 and sell it today you would earn a total of 98.00 from holding Verve Therapeutics or generate 18.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Beam Therapeutics vs. Verve Therapeutics
Performance |
| Timeline |
| Beam Therapeutics |
| Verve Therapeutics |
Beam Therapeutics and Verve Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Beam Therapeutics and Verve Therapeutics
The main advantage of trading using opposite Beam Therapeutics and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Beam Therapeutics position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.| Beam Therapeutics vs. Editas Medicine | Beam Therapeutics vs. Crispr Therapeutics AG | Beam Therapeutics vs. Caribou Biosciences | Beam Therapeutics vs. Verve Therapeutics |
| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |